Pfizer Partners with China Cardiovascular Association to Tackle Heart Failure
US-based Pfizer (NYSE: PFE) has initiated a strategic partnership with the China Cardiovascular Association (CCA),...
CVD
Organon Partners with Alibaba Health to Enhance Chronic Disease Management
Organon & Co. (NYSE: OGN), a firm with a strong focus on women’s health that...
Ji Xing Pharmaceuticals’ Omecamtiv Mecarbil Accepted for Review by CDE
Shanghai-based Ji Xing Pharmaceuticals, backed by RTW Investments, announced that a market filing for its...
Innovent Biologics’ Tafolecimab Shows Strong LDL-C Reduction in Phase III Study
China-based Innovent Biologics, Inc. (HKG: 1801) announced the results of the Phase III CREDIT-1 study...
Pulnovo Medical Raises ‘Tens of Millions’ in New Financing Round
Pulnovo Medical, a pulmonary hypertension (PH) medical device maker based in Wuxi, has reportedly raised...
Eccogene Gains FDA Approval for Phase I Study of ECC5004
Shanghai-based Eccogene has announced receiving approval from the US FDA to initiate a Phase I...
AccuMedical’s Blood Flow-Guided Stent Wins NMPA Approval for Brain Aneurysms
AccuMedical Beijing Ltd has secured approval from China’s National Medical Products Administration (NMPA) for its...
LEPU ScienTech Medical Technology Sets IPO Price Range Ahead of Hong Kong Listing
China-based LEPU ScienTech Medical Technology (Shanghai) Co., Ltd is gearing up for an initial public...
Venmedtech Raises Series B+ Funding for Iliac Vein Stent and Product R&D
Venmedtech, a Suzhou-based one-stop intravenous therapy product platform, has reportedly raised “tens of millions” of...
Easy-Flow Medical Secures Angel Funding for Peripheral Device Development
China-based peripheral interventional device manufacturer Shanghai Easy-Flow Medical Tech Co., Ltd has reportedly raised “tens...
NMPA Approves Beijing Union Strong’s Intracranial Aneurysm Surgical Planning Software
The National Medical Products Administration (NMPA) has approved the marketing of Beijing Union Strong Technology...
China’s NMPA Proposes Reforms to Enhance Radiopharmaceutical Review and Approval
China’s National Medical Products Administration (NMPA) has released a draft proposal titled “Opinions on Reforming...
MicroPort CardioFlow’s Alwide Plus Balloon Catheter Approved in Colombia
MicroPort CardioFlow Medtech Co., Ltd (HKG: 2160), a spin-off of China-based MicroPort Scientific Corp (HKG:...
Sino Medical Sciences Gains Approval for Drug-Eluting Stent System
China-based Sino Medical Sciences Technology Inc. (SHA: 688108) has announced that it has received market...
Boston Scientific Completes First Surgery with RotaPro in China
US-based Boston Scientific Corporation (NYSE: BSX) has announced the completion of the first surgery using...
Lepu Medtech Receives Approval for Innovative Peripheral Cutting Balloon
China-based cardiovascular disease solutions provider Lepu Medical Technology (Beijing) Co., Ltd (SHE: 300003) has announced...
Bio-Heart Plans STAR Board IPO After Hong Kong Debut to Advance Cardiovascular Therapies
Shanghai Bio-Heart Biological Technology Co., Ltd (HKG: 2185), a leading Chinese innovator in interventional cardiovascular...
JJET Raises RMB 700M in Series A+ and B Rounds for Cardiac Electrophysiology Products
JJET, a Chengdu-based specialist in cardiac electrophysiology interventional therapy, has completed Series A+ and Series...
Bio-Heart’s BIOHEART-II Study Meets Primary Endpoint for Bioresorbable Scaffolds
China-based Shanghai Bio-Heart Biological Technology Co., Ltd (HKG: 2185) announced that the BIOHEART-II study for...
Elite Pharma Raises RMB100m in Series B Financing for Drug Delivery Tech
Shanghai-based Elite Pharmaceutical Technology Inc. has reportedly raised nearly RMB100 million (USD14.8 million) in a...